Sage Journals: Discover world-class research

Free access

Review article

First published 2018-1

Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential

Michael E. Røder

Sage Open Chronic Disease

Open access

Research article

First published 2019

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Cameron M. Kieffer, Andrew S. Robertson

Therapeutic Innovation & Regulatory Science

Open access

Brief report

First published 2020-11

Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA

Sujoy Ghosh, Pradip Mukhopadhyay, Prabhakar Pandey [...]

Diabetes & Vascular Disease Research

Open access

Research article

First published 2020-11

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

Aslam Amod, John B Buse, Darren K McGuire [...]

Diabetes & Vascular Disease Research

Open access

Review article

First published 2026

GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence

Valentini Samanidou, Konstantinos Tsamis, Alexandr Ceasovschih [...]

Journal of Central Nervous System Disease

Retricted access

Review article

First published 2024-10

Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials

Anastasia Adamou, Fotios Barkas, Haralampos Milionis [...]

International Journal of Stroke

Open access

Review article

First published 2022

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

Bernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen [...]

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2024-8

Racial,ethnic and regional differences in the effect of sodium–glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials

Setor K Kunutsor, Kamlesh Khunti, Samuel Seidu

Journal of the Royal Society of Medicine

Search results